Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
AJNR Am J Neuroradiol ; 38(7): 1356-1361, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28495947

RESUMEN

BACKGROUND AND PURPOSE: The Embolus Retriever with Interlinked Cages (ERIC) device is a novel stent retriever for mechanical thrombectomy. It consists of interlinked cages and could improve procedural benchmarks and clinical outcome compared with classic stent retrievers. This study compares the rates of recanalization, favorable clinical outcome, procedural adverse events, and benchmarks between the ERIC device and classic stent retrievers. MATERIALS AND METHODS: From 545 patients treated with thrombectomy between 2012 and 2015, 316 patients were included. The mean age was 69 ±13 years, the mean baseline NIHSS score was 17 ± 5, and 174 (55%) were men. The ERIC was used as the primary thrombectomy device in 59 (19%) patients. In a propensity score matched analysis including the NIHSS score, clot location, delay to groin puncture, neurointerventionalist, and anesthetic management, 57 matched pairs were identified. RESULTS: Patients treated with the ERIC device compared with classic stent retrievers showed equal rates of recanalization (86% versus 81%, P = .61), equal favorable 3-month clinical outcome (mRS 0-2: 46% versus 40%, P = .71), and procedural adverse events (28% versus 30%, P = 1.00). However, in patients treated with the ERIC device, thrombectomy procedures were less time-consuming (67 versus 98 minutes, P = .009) and a rescue device was needed less often (18% versus 39%, P = .02) compared with classic stent retrievers. CONCLUSIONS: Mechanical thrombectomy with the ERIC device is effective and safe. Rates of favorable procedural and clinical outcomes are at least as good as those with classic stent retrievers. Of note, the ERIC device might be time-saving and decrease the need for rescue devices. These promising results call for replication in larger prospective clinical trials.


Asunto(s)
Isquemia Encefálica/cirugía , Embolia Intracraneal/cirugía , Accidente Cerebrovascular/cirugía , Instrumentos Quirúrgicos , Trombectomía/métodos , Adulto , Anciano , Anciano de 80 o más Años , Anestesia , Estudios de Casos y Controles , Remoción de Dispositivos , Femenino , Ingle , Humanos , Masculino , Persona de Mediana Edad , Cuidados Posoperatorios , Puntaje de Propensión , Punciones , Estudios Retrospectivos , Stents , Instrumentos Quirúrgicos/efectos adversos , Trombectomía/efectos adversos , Resultado del Tratamiento
2.
Acta Neurol Scand ; 124(1): 40-4, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20726843

RESUMEN

BACKGROUND: Patients with acute ischemic stroke and atrial fibrillation are at increased risk of stroke progression and recurrence. We sought to assess whether D-dimer and other markers of hemostatic activation could predict these adverse events in such patients. METHOD: Blood samples were obtained from patients included in the Heparin in Acute Embolic Stroke Trial. Stroke progression was defined as a ≥3-point worsening on the Scandinavian Stroke Scale during the first 48 h after randomization. Blood samples were analyzed for D-dimer, prothrombin fragment 1 + 2, soluble fibrin monomer, and C-reactive protein. RESULTS: A total of 382 patients were included in the analyses. Levels of D-dimer and other markers of hemostatic activation were not significantly higher in patients with stroke progression than in other patients (D-dimer median values: 1025 ng/ml vs 970 ng/ml, P = 0.73). The same was true for recurrent stroke (D-dimer: 720 ng/ml vs 973 ng/ml, P = 0.96), and the combined endpoint of stroke progression, recurrent stroke, and death (D-dimer: 991 ng/ml vs 970 ng/ml, P = 0.91). Multivariable analyses did not alter the results. CONCLUSION: D-dimer and other markers of hemostatic activation were not associated with stroke progression, recurrent stroke, or death in patients with acute ischemic stroke and atrial fibrillation.


Asunto(s)
Fibrilación Atrial/sangre , Isquemia Encefálica/sangre , Progresión de la Enfermedad , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Accidente Cerebrovascular/sangre , Anciano , Anciano de 80 o más Años , Fibrilación Atrial/complicaciones , Isquemia Encefálica/complicaciones , Proteína C-Reactiva , Femenino , Humanos , Masculino , Fragmentos de Péptidos/sangre , Precursores de Proteínas/sangre , Protrombina , Accidente Cerebrovascular/complicaciones
3.
Neurology ; 71(17): 1313-8, 2008 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-18936423

RESUMEN

OBJECTIVE: To determine whether prestroke level of physical activity influenced stroke severity and long-term outcome. METHODS: Patients included into the present analyses represent a subset of patients with first-ever stroke enrolled into the ExStroke Pilot Trial. Patients with ischemic stroke were randomized in the ExStroke Pilot Trial to an intervention of repeated instructions and encouragement to increase the level of physical activity or to a control group. Prestroke level of physical activity was assessed retrospectively by interview using the Physical Activity Scale for the Elderly (PASE) questionnaire. The PASE questionnaire quantifies the amount of physical activity done during a 7-day period. In this prospectively collected patient population initial stroke severity was measured using the Scandinavian Stroke Scale and long-term outcome was assessed after 2 years using the modified Rankin Scale. Statistical analyses were done using ordinal logistic regression. RESULTS: Data from 265 patients were included with a mean (SD) age of 68.2 (12.2) years. Confirming univariable analyses, multivariable analyses showed that patients with physical activity in the top quartile more likely presented with a less severe stroke, OR 2.54 (95% CI 1.30-4.95), and had a decreased likelihood of poor outcome, OR 0.46 (95% CI 0.22-0.96), compared to patients in the lowest quartile. CONCLUSIONS: In the present study physical activity prior to stroke was associated with a less severe stroke and better long-term outcome.


Asunto(s)
Actividad Motora/fisiología , Índice de Severidad de la Enfermedad , Accidente Cerebrovascular/prevención & control , Accidente Cerebrovascular/fisiopatología , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Internacionalidad , Masculino , Persona de Mediana Edad , Proyectos Piloto , Estudios Prospectivos , Estudios Retrospectivos , Accidente Cerebrovascular/etiología , Encuestas y Cuestionarios , Tiempo , Resultado del Tratamiento
4.
Pharm Res ; 15(7): 972-8, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9688046

RESUMEN

PURPOSE: To develop an efficient method for generating representative conformations for calculation of the conformationally dependent molecular surface area, and to investigate the relation between this parameter and the permeability in Caco-2 cells. METHODS: High temperature molecular dynamics (MD) simulations were used to obtain 1000 conformations of six beta-blocking agents and their prodrugs. The Boltzmann averaged (B.a.) polar surface area of the 1000 conformations was correlated to the apparent permeability coefficients (Papp) for transport across filter-grown Caco-2 cells. RESULTS: Sampling of 1000 conformations during the MD simulations was sufficient for obtaining a representative set of conformations. The B.a. polar water accessible surface area (PWASA) yielded an excellent linear correlation with Papp for both series of compounds under study (R2 = 0.98). Thus, the improved permeability of the prodrugs could be explained by a reduced PWASA. The improvement of permeability after derivatization correlated positively with the size of the non-polar water accessible surface area-suggesting a synergistic effect of the cyclopropyl and the non-polar parts of the molecule to shield the polar parts from contact with water. CONCLUSIONS: An efficient method for generating the representative conformations for calculation of the B.a. polar surface area has been established. An excellent linear correlation explaining the improved permeability of the prodrugs was obtained.


Asunto(s)
Antagonistas Adrenérgicos beta/química , Antagonistas Adrenérgicos beta/farmacocinética , Absorción Intestinal , Células CACO-2/metabolismo , Permeabilidad de la Membrana Celular/fisiología , Fenómenos Químicos , Química Física , Simulación por Computador , Calor , Humanos , Modelos Químicos , Conformación Molecular , Profármacos/química , Profármacos/farmacocinética , Relación Estructura-Actividad , Propiedades de Superficie , Termodinámica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA